Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

BioAge Labs (BIOA) Shares Outstanding (2023 - 2026)

BioAge Labs' Shares Outstanding history spans 3 years, with the latest figure at $37.4 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 4.29% to $37.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $37.4 million, a 4.29% increase, with the full-year FY2025 number at $37.4 million, up 4.29% from a year prior.
  • Shares Outstanding hit $37.4 million in Q4 2025 for BioAge Labs, up from $35.9 million in the prior quarter.
  • Over the last five years, Shares Outstanding for BIOA hit a ceiling of $37.4 million in Q4 2025 and a floor of $1.7 million in Q4 2023.
  • Historically, Shares Outstanding has averaged $24.5 million across 3 years, with a median of $35.9 million in 2024.
  • Biggest five-year swings in Shares Outstanding: surged 2042.46% in 2024 and later rose 4.29% in 2025.
  • Tracing BIOA's Shares Outstanding over 3 years: stood at $1.7 million in 2023, then surged by 2042.46% to $35.9 million in 2024, then rose by 4.29% to $37.4 million in 2025.
  • Business Quant data shows Shares Outstanding for BIOA at $37.4 million in Q4 2025, $35.9 million in Q3 2025, and $35.9 million in Q2 2025.